硫酸氢氯吡格雷与阿司匹林治疗冠心病的临床疗效

打开文本图片集

中图分类号：R541.4 文献标识码：A文章编号：1006-1959（2025）14-0127-04

DOI：10.3969/j.issn.1006-1959.2025.14.025

Abstract：Obecialalacofoesledspinreamntfoarartsaly 78coronaryheartdiseasepatientshoeredagosdndtreatedatourhospitalfoMay23andMay24asdysubectsUsingtheado numbertablemethod，patientsweredividedintoacontrolgroup（n=39）receivingaspirinmonotherapyandanobservationgroup（ n=. 39）receiving clopidogestebdialcostrectidt （CO）trokdo） activatedri fcardiovsdlirredd groups.Results Compared with the total effective rate of the control group（ 87.18% ），the total effective rate of the observation group （94.87 % ）was higher（O.O5）mpdifoeatteVEFfoouseetreatdaedirol group，the LVEF，CO and SV of the observation group were higher（ P <0.05）.Compared with before treatment，FIB decreased and APTT and PT increasedfterreaetittoosdoaeditheotloupendAdereigerieao group（ P< 0.05）.Compared with the incidence of adverse reactions in the control group （7.69 % ），the incidence of adverse reactions in the observation group （5.13 % ）waslower，but thedifferencewasnotstatisticallysignificant（ P> 0.05）.Compared with the incidence of cardiovascular adverse events in the control group（ 12.82% ），the incidence of cardiovascular adverse events in the observation group （2.56 % ）was lower（P<0.05）.Conclusion Clopidogrelstedspalireatfoararcpeealiatf cardiacfunctionandvascularendothelialfunctioneducemyocardialinjurandhavefeweradversereactionsMeanhile，itanprevent cardiovascular adverse events and has high clinical application value.

KeyWords：Clopidogrel bisulfate;Aspirin;Coronary heart disease;Coagulation function

冠心病（coronaryheartdisease）是一种临床常见的心血管疾病，其病理基础为冠状动脉发生粥样硬化性病变，进而引发心肌组织供血不足和氧合障碍。（剩余4960字）